A CRITIQUE ON THE EVALUATION AND MODE OF ACTION OF ANTIESTROGENSSANKARAN MS; PRASAD MRN.1972; GYNECOL. INVEST.; SWITZ.; DA. 1972; VOL. 3; NO 1-4; PP. 142-147; BIBL. 1 P.Article

Effect of toremifene on estrogen primed vaginal mucosa in postmenopausal womenMAÊENPAÊAÊ, J; SOÊDERSTROÊM, K.-O; GROÊNROOS, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 221-223, issn 0022-4731, 3 p.Conference Paper

Purification a homogénéité du site de liaison des antioestrogènes (ABS); évaluation des rôles respectifs d'ABS et du récepteur des oestrogènes dans l'activité antiréplicative du tamoxifène = Purification to homogeneity of the antioestrogen binding site (ABS); evaluation of the respective roles of ABS and of the oestrogen receptor in the antireplicative activity of tamoxifenChailleux, Catherine; Bayard, Francis.1992, 153 p.Thesis

ANTITUMOR ACTIVITIES AND ESTROGEN RECEPTOR INTERACTIONS OF THE METABOLITES OF THE ANTIESTROGENS C1628 AND U23, 469 IN THE 7,12-DIMETHYLBENZ (A) ANTHRACENE-INDUCED RAT MAMMARY TUMOR SYSTEMRORKE EA; KATZENELLENBOGEN BS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 4; PP. 1257-1262; BIBL. 37 REF.Article

ACTION OF AN ESTROGEN ANTAGONIST IN INTACT AND OVARIECTOMIZED RATSPERRY K; DIPASQUALE G; FERGUSON E et al.1973; CONTRACEPTION; U.S.A.; DA. 1973; VOL. 7; NO 3; PP. 231-242; BIBL. 2P.1/2Article

Additive and synergistic antitumor effects with toremifene and interferonsKANGAS, L; CANTELL, K; SCHELLEKENS, H et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 259-262, issn 0022-4731, 4 p.Conference Paper

Design of novel antiestrogensHENDRY, L. B; CHU, C. K; ROSSER, M. L et al.Journal of steroid biochemistry and molecular biology. 1994, Vol 49, Num 4-6, pp 269-280, issn 0960-0760Conference Paper

La contraception par les progestatifs normodosés = Contraception using nomodose progestinsPELISSIER-LANGBORT, C.Contraception fertilité sexualité (1973). 1984, Vol 12, Num 10, pp 1099-1109, issn 0301-861XArticle

Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cellsSCHNEIDER, J; HUH, M. M; BRADLOW, H. L et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 8, pp 4840-4845, issn 0021-9258Article

Review of the pharmacological properties of toremifeneKANGAS, L.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 191-195, issn 0022-4731, 5 p.Conference Paper

Nonendocrine pathways and endocrine resistance: Observations with antiestrogens and signal transduction inhibitors in combinationNICHOLSON, Robert I; HUTCHESON, Iain R; KNOWLDEN, Janice M et al.Clinical cancer research. 2004, Vol 10, Num 1, pp 346s-354s, issn 1078-0432, 2Conference Paper

An evaluation of tamoxifen as a partial agonist by classical receptor theory ― an explanation of the dual action of tamoxifenMACNAB, M. W; TALLARIDA, R. J; JOSEPH, R et al.European journal of pharmacology. 1984, Vol 103, Num 3-4, pp 321-326, issn 0014-2999Article

Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitroJORDAN, V. C; LIEBERMAN, M. E; CORMIER, E et al.Molecular pharmacology. 1984, Vol 26, Num 2, pp 272-278, issn 0026-895XArticle

Mécanisme d'action des antioestrogènes: interaction avec les systèmes régulateurs de l'AMPc = Mechanism of action of antoestrogens: Interaction with cyclic AMP regulatory systemsFanidi, Abdallah; Laugier, Christian.1990, 392 p.Thesis

SUPPRESSION OF LACTATION BY AN ANTIESTROGEN, TAMOXIFENSHAABAN MM.1975; EUROP. J. OBSTETR. GYNECOL. REPROD. BIOL.; NETHERL.; DA. 1975; VOL. 4; NO 5; PP. 167-169; BIBL. 9REF.Article

THE EFFECT OF ANTIESTROGENS ON THE NUCLEAR BINDING OF THE ESTROGEN RECEPTOR = EFFET DES ANTIOESTROGENES SUR LA LIAISON NUCLEAIRE DU RECEPTEUR OESTROGENIQUERUH TS; RUH MF.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 24; NO 2; PP. 209-224; BIBL. 1P.1/2Article

L'EFFET ANTIOESTROGENESJAMIN C; GAYRAUD M; HAZARD J et al.1982; SEM. HOP.; ISSN 0037-1777; FRA; DA. 1982; VOL. 58; NO 32; PP. 1793-1799; ABS. ENG; BIBL. 25 REF.Article

SYNTHESIS AND ANTIESTROGENIC ACTIVITY OF 2,4-BIS (BROMOMETHYL)-ESTRONE METHYL ETHER: A BIFUNCTIONAL ALKYLATING STEROID = SYNTHESE ET ACTIVITE ANTI-OESTROGENIQUE DU 2,4-BIS (BROMOMETHYL)-OESTRONE METHYL ETHER: STEROIDE ALKYLANT BIFONCTIONNELNARASHIMHA RAO KANAMARLAPUDI; SWEET F; WARREN JC et al.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 24; NO 1; PP. 63-77; BIBL. 13REF.Article

2ALPHA -3ALPHA -EPITHIO-5ALPHA -ANDROSTAN-17BETA -YL 1-METHOXYCYCLOPENTYL ETHER (10364-S), A NEW ORALLY ACTIVE ANTI-ESTROGENIC STEROID = LE 2ALPHA -3ALPHA -EPITHIO-5ALPHA -ANDROSTAN-17BETA -YL-1-METHOXY-CYCLOPENTYL-ETHER (10364-S), NOUVEAU STEROIDE ANTI-OESTROGENIQUE ACTIF PAR VOIE ORALEMIYAKE T; HORI T; KATO G et al.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 23; NO 6; PP. 929-937; BIBL. 17REF.Article

INACTIVATION DE L'ACTION BIOLOGIQUE DES OESTROGENES ET DE L'HORMONE DE CROISSANCE PAR DES ANTICORPS INDUITS PAR UN COMPLEXE INACTIF DE SOMATOTROPHINE ET D'OESTRONE HUMAINESBERSHTEJN LM; SOFRONOV BN; PEMIZOV AL et al.1973; BJULL. EKSPER. BIOL. MED.; S.S.S.R.; DA. 1973; VOL. 75; NO 2; PP. 85-88; ABS. ANGL.; BIBL. 14 REF.Article

STUDIES ON THE ANTI-OESTROGENIC AND OESTROGEN-LIKE ACTION OF CLOMIPHENE CITRATE IN WOMENCZYGAN PJ; SCHULZ KD.1972; GYNECOL. INVEST.; SWITZ.; DA. 1972; VOL. 3; NO 1-4; PP. 126-134; BIBL. 4REF.Article

PREGNANCY FOLLOWING 29 CYCLES OF CLOMIPHENE CITRATE THERAPY: A CASE REPORT.MARCH CM; ISRAEL R; MISHELL DR JR et al.1976; AMER. J. OBSTETR. GYNECOL.; U.S.A.; DA. 1976; VOL. 124; NO 2; PP. 209-210; BIBL. 2 REF.Article

SPERMATOGENIC ARREST PRODUCED IN THE ADULT MALE RAT BY 19-NORSPIROXENONE, A POTENT ANTI-ESTROGEN. = ARRET DE LA SPERMATOGENESE PRODUIT CHEZ LE RAT MALE PAR LA NOR-19 SPIROXENONE, UN ANTI-OESTROGENE PUISSANTSHAPIRO BH; GOLDMAN AS.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 150; NO 1; PP. 226-228; BIBL. 17 REF.Article

ANTI-ESTROGENS AND PLASMA PROTEINS. I. CLOMIPHENE AND ISOMERS, ETHAMOXYTRIPHETOL, U-11, 100A AND U-11, 555A = ANTI-OESTROGENES ET PROTEINES PLASMATIQUES. I. CLOMIPHENE ET ISOMERES ETHAMOXYTRIPHETOL, U-11, 100 A ET U-11, 555 ABARBOSA J; SEAL US; DOE RP et al.1973; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1973; VOL. 36; NO 4; PP. 666-678; BIBL. 46REF.Article

MODE OF ACTION OF LN 1643 (A TRIPHENYLBROMOETHYLENE ANTIESTROGEN): PROBABLE MEDIATION BY THE ESTROGEN RECEPTOR AND HIGH AFFINITY METABOLITEBORGNA JL; COEZY E; ROCHEFORT H et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 20; PP. 3187-3191; BIBL. 28 REF.Article